Fibrocell Science (FCSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,795 | -2,901 | -16,240 | -19,140 | -19,025 |
| Depreciation Amortization | 202 | 101 | 470 | 368 | 184 |
| Accounts payable and accrued liabilities | -1,976 | -1,906 | 1,430 | 921 | 928 |
| Other Working Capital | -1,638 | -1,918 | 1,884 | 1,204 | 573 |
| Other Operating Activity | 1,731 | 1,863 | -4,581 | 3,768 | 8,357 |
| Operating Cash Flow | $-7,476 | $-4,761 | $-17,037 | $-12,879 | $-8,983 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -83 | -35 | -433 | -348 | -243 |
| Investing Cash Flow | $-83 | $-35 | $-433 | $-348 | $-243 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,996 | 24 | 9,749 | N/A | 0 |
| Other Financing Activity | -444 | -444 | 7,623 | 7,623 | 7,623 |
| Financing Cash Flow | $5,552 | $-420 | $17,372 | $7,623 | $7,623 |
| Beginning Cash Position | 17,417 | 17,417 | 17,515 | 17,515 | 17,515 |
| End Cash Position | 15,410 | 12,201 | 17,417 | 11,911 | 15,912 |
| Net Cash Flow | $-2,007 | $-5,216 | $-98 | $-5,604 | $-1,603 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,476 | -4,761 | -17,037 | -12,879 | -8,983 |
| Capital Expenditure | -83 | -35 | -433 | -348 | -243 |
| Free Cash Flow | -7,559 | -4,796 | -17,470 | -13,227 | -9,226 |